These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 31302840)

  • 1. Adapting traditional content validation methods to fit purpose: an example with a novel video assessment and training materials in Duchenne muscular dystrophy (DMD).
    White MK; Leffler M; Rychlec K; Jones C; McSherry C; Walker L; Kosinski M
    Qual Life Res; 2019 Nov; 28(11):2979-2988. PubMed ID: 31302840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a Clinical Global Impression of Change (CGI-C) and a Caregiver Global Impression of Change (CaGI-C) measure for ambulant individuals with Duchenne muscular dystrophy.
    Staunton H; Trennery C; Arbuckle R; Guridi M; Zhuravleva E; Furlong P; Fischer R; Hall R
    Health Qual Life Outcomes; 2021 Jul; 19(1):184. PubMed ID: 34311756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The PedsQL in pediatric patients with Duchenne muscular dystrophy: feasibility, reliability, and validity of the Pediatric Quality of Life Inventory Neuromuscular Module and Generic Core Scales.
    Davis SE; Hynan LS; Limbers CA; Andersen CM; Greene MC; Varni JW; Iannaccone ST
    J Clin Neuromuscul Dis; 2010 Mar; 11(3):97-109. PubMed ID: 20215981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measuring Duchenne muscular dystrophy impact: development of a proxy-reported measure derived from PROMIS item banks.
    Schwartz CE; Stark RB; Cella D; Borowiec K; Gooch KL; Audhya IF
    Orphanet J Rare Dis; 2021 Nov; 16(1):487. PubMed ID: 34809687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychometric properties of the Zarit Caregiver Burden Interview administered to caregivers to patients with Duchenne muscular dystrophy: a Rasch analysis.
    Landfeldt E; Mayhew A; Straub V; Bushby K; Lochmüller H; Lindgren P
    Disabil Rehabil; 2019 Apr; 41(8):966-973. PubMed ID: 29254382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and content validation of the Muscular Dystrophy Child Health Index of Life with Disabilities questionnaire for children with Duchenne muscular dystrophy.
    Propp R; McAdam L; Davis AM; Salbach NM; Weir S; Encisa C; Narayanan UG
    Dev Med Child Neurol; 2019 Jan; 61(1):75-81. PubMed ID: 30058069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toward patient-centered treatment goals for duchenne muscular dystrophy: insights from the "Your Voice" study.
    Schwartz CE; Jackson S; Valentine J; Miller N; Lowes L; Edwards D; McSherry C; Savva D; Lowe A; McSherry J; Engel P
    Orphanet J Rare Dis; 2023 Apr; 18(1):90. PubMed ID: 37081508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Producing a preference-based quality of life measure for people with Duchenne muscular dystrophy: a mixed-methods study protocol.
    Powell PA; Carlton J; Rowen D; Brazier JE
    BMJ Open; 2019 Mar; 9(3):e023685. PubMed ID: 30852532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is functional dependence of Duchenne muscular dystrophy patients determinant of the quality of life and burden of their caregivers?
    de Moura MC; Wutzki HC; Voos MC; Resende MB; Reed UC; Hasue RH
    Arq Neuropsiquiatr; 2015 Jan; 73(1):52-7. PubMed ID: 25608128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reliability and validity of the Thai version of the Pediatric Quality of Life inventory™ 3.0 Duchenne Muscular Dystrophy module in Thai children with Duchenne Muscular Dystrophy.
    Thongsing A; Likasitwattanakul S; Sanmaneechai O
    Health Qual Life Outcomes; 2019 May; 17(1):76. PubMed ID: 31046775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reliability and construct validity of the Duchenne Video Assessment.
    Contesse MG; Sapp ATL; Apkon SD; Lowes LP; Dalle Pazze L; Leffler MG
    Muscle Nerve; 2021 Aug; 64(2):180-189. PubMed ID: 34050939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient- and caregiver-reported impact of symptoms in Duchenne muscular dystrophy.
    Rosero S; Weinstein J; Seabury J; Varma A; Dilek N; Zizzi C; Coffey M; Greco B; Heatwole J; Alexandrou D; Guntrum D; Ciafaloni E; Heatwole C
    Muscle Nerve; 2024 Jul; 70(1):120-129. PubMed ID: 38720616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A qualitative study to understand the Duchenne muscular dystrophy experience from the parent/patient perspective.
    Brown V; Merikle E; Johnston K; Gooch K; Audhya I; Lowes L
    J Patient Rep Outcomes; 2023 Dec; 7(1):129. PubMed ID: 38085412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measuring quality of life in Duchenne muscular dystrophy: a systematic review of the content and structural validity of commonly used instruments.
    Powell PA; Carlton J; Woods HB; Mazzone P
    Health Qual Life Outcomes; 2020 Aug; 18(1):263. PubMed ID: 32746836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient and caregiver perspectives on guideline adherence: the case of endocrine and bone health recommendations for Duchenne muscular dystrophy.
    Denger B; Kinnett K; Martin A; Grant S; Armstrong C; Khodyakov D
    Orphanet J Rare Dis; 2019 Aug; 14(1):205. PubMed ID: 31429780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eteplirsen Treatment for Duchenne Muscular Dystrophy: A Qualitative Patient Experience Study.
    Iff J; Carmichael C; McKee S; Sehinovych I; McNeill C; Tesi-Rocha C; Henricson E; Muntoni F; Kitchen H
    Adv Ther; 2024 Aug; 41(8):3278-3298. PubMed ID: 38958840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "You Take This Day by Day, Come What May": A Qualitative Study of the Psychosocial Impacts of Living with Duchenne Muscular Dystrophy.
    Bever A; Audhya I; Szabo SM; Mickle A; Feeny D; Malone D; Neumann P; Iannaccone S; Gooch K
    Adv Ther; 2024 Jun; 41(6):2460-2476. PubMed ID: 38709395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Social difficulties and care burden of adult Duchenne muscular dystrophy in Japan: a questionnaire survey based on the Japanese Registry of Muscular Dystrophy (Remudy).
    Mori-Yoshimura M; Ishigaki K; Shimizu-Motohashi Y; Ishihara N; Unuma A; Yoshida S; Nakamura H
    Orphanet J Rare Dis; 2024 Apr; 19(1):182. PubMed ID: 38689355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and Reliability of the Functional Evaluation Scale for Duchenne Muscular Dystrophy, Gait Domain: A Pilot Study.
    de Carvalho EV; Hukuda ME; Escorcio R; Voos MC; Caromano FA
    Physiother Res Int; 2015 Sep; 20(3):135-46. PubMed ID: 25521365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Duchenne muscular dystrophy and caregiver burden: a systematic review.
    Landfeldt E; Edström J; Buccella F; Kirschner J; Lochmüller H
    Dev Med Child Neurol; 2018 Oct; 60(10):987-996. PubMed ID: 29904912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.